Hosted on MSN6d
Dexcom launches first over-the-counter continuous glucose monitor. Here's what it's like
Dexcom launched its first over-the-counter continuous glucose monitor called Stelo on Monday. Users can buy a one-month supply online for $99, or sign up for an ongoing subscription at $89 a month.
Glucose monitors for diabetes have finally been funded – but a chronic workforce shortage will limit the benefits
To meet international guidelines, New Zealand needs to double the workforce that supports people with diabetes. Unless that ...
This Is What Whales Are Betting On DexCom
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an ...
Yahoo Finance8d
Down More Than 50% From Its High, Is DexCom Stock a Buy?
A top healthcare stock to own over the years has been DexCom (NASDAQ: DXCM). The company makes continuous glucose monitors ...
ITWire23d
Dexcom releases new smart wearable for diabetic people
Dexcom unveiled its Dexcom G7 continuous glucose monitoring (CGM) for people with diabetes age two years and older in Australia. The Dexcom G7 is a wearable and sends real-time glucose readings ...
DXCM INVESTOR UPDATE: BFA Law Notifies DexCom, Inc. Investors to Contact the Firm Before October 21 Deadline in Securities Fraud Class Action Lawsuit
New York, New York-- (Newsfile Corp. - October 12, 2024) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against DexCom, Inc. (NASDAQ: DXCM) and ...
Down More Than 50%, Is DexCom Stock a Bargain Now?
DexCom markets one of the world's most popular constant blood glucose monitors (CGM). These discreet devices adhere to the ...
Benzinga.com12d
DexCom (NASDAQ:DXCM) Stock Quotes, Forecast and News Summary
It's the one you want, not Carnival." Avi Kapoor Dexcom's Stelo Device Brings Affordable Continuous Glucose Monitoring To Type 2 Diabetes Patients DexCom's Stelo Glucose Biosensor System ...
Is DexCom a Millionaire Maker?
Today, DexCom is the leading CGM company, with an estimated 40% market share. Importantly, CGM products are relatively nascent. DexCom generates nearly $4 billion in annual sales on a user base of ...
Nasdaq10d
Here's What to Expect From DexCom's Next Earnings Report
With a market cap of $27.1 billion, DexCom, Inc. (DXCM) is a leading medical device company, specializing in continuous glucose monitoring (CGM) systems for diabetes management. The San Diego ...
bovnews23h
DexCom Inc (DXCM) Stock Sees Market Value Hit $26.89 billion: What Are the Implications?
On Tuesday, DexCom Inc (DXCM) stock saw a decline, ending the day at $67.1 which represents a decrease of $-2.08 or -3.01% from the prior close of $69.18. The stock opened at $69 and touched a low of ...
AOL15d
Down More Than 50%, Is DexCom Stock a Bargain Now?
DexCom markets one of the world's most popular constant blood glucose monitors (CGM). These discreet devices adhere to the back of a person's arm and steadily measure their blood sugar ...